| Q57612892 | A Randomized Trial on the Efficacy of Group Psychoeducation in the Prophylaxis of Recurrences in Bipolar Patients Whose Disease Is in Remission |
| Q37631793 | A critical update on psychological interventions for bipolar disorders |
| Q36513316 | A meta-analysis of relapse rates with adjunctive psychological therapies compared to usual psychiatric treatment for bipolar disorders |
| Q35947317 | A perspective on the use of psychoeducation, cognitive-behavioral therapy and interpersonal therapy for bipolar patients |
| Q44723795 | Acute and continuation risperidone monotherapy in mania. |
| Q53900501 | Adjunctive gabapentin treatment of bipolar disorder. |
| Q44649446 | Adjunctive topiramate in bipolar II disorder |
| Q50690407 | Adolescents and young adults who are not in employment, education, or training. |
| Q38174533 | Advancing psychotherapy and evidence-based psychological interventions. |
| Q57612969 | Alpha-1-acid glycoprotein in major depressive disorder |
| Q55080509 | Analysis of the Influence of microRNAs in Lithium Response in Bipolar Disorder. |
| Q42081136 | Anticonvulsants in the treatment of aggression in the demented elderly: an update |
| Q47615587 | Are patients with bipolar disorder and comorbid attention-deficit hyperactivity disorder more neurocognitively impaired? |
| Q48048548 | Association between Sirtuin 1 Gene rs10997870 Polymorphism and Suicide Behaviors in Bipolar Disorder. |
| Q46686779 | Association of Polygenic Score for Schizophrenia and HLA Antigen and Inflammation Genes With Response to Lithium in Bipolar Affective Disorder: A Genome-Wide Association Study. |
| Q90589658 | Association of polygenic score for major depression with response to lithium in patients with bipolar disorder |
| Q57612607 | Atypical depression is associated with suicide attempt in bipolar disorder |
| Q57612609 | Authors' reply |
| Q57612212 | Behavioural biomarkers and mobile mental health: a new paradigm |
| Q31105813 | Big Data in mental health: a challenging fragmented future |
| Q57612970 | Bipolar II disorder and comorbidity |
| Q58465402 | Bipolar disorder |
| Q38503657 | Bipolar disorder and antibodies against the N-methyl-d-aspartate receptor: A gate to the involvement of autoimmunity in the pathophysiology of bipolar illness. |
| Q44071452 | Bipolar disorder in the elderly: a cohort study comparing older and younger patients. |
| Q48084899 | Bipolar disorder with comorbid attention-deficit and hyperactivity disorder. Main clinical features and clues for an accurate diagnosis. |
| Q57612952 | Bipolar disorder, schizoaffective disorder and schizophrenia: epidemiologic, clinical and prognostic differences |
| Q38275720 | Bipolar disorders in the new DSM-5 and ICD-11 classifications |
| Q48886105 | Bipolar mixed episodes and antidepressants: a cohort study of bipolar I disorder patients |
| Q51903049 | Clinical and prognostic implications of seasonal pattern in bipolar disorder: a 10-year follow-up of 302 patients. |
| Q51918274 | Clinical and therapeutic implications of predominant polarity in bipolar disorder. |
| Q50920723 | Clinical correlates of first-episode polarity in bipolar disorder. |
| Q57612954 | Clinical correlates of psychiatric comorbidity in bipolar I patients |
| Q77790344 | Clinical correlates of psychiatric comorbidity in bipolar I patients |
| Q48530125 | Clinical implications of a staging model for bipolar disorders |
| Q49123108 | Clinical value of 99mTc-HMPAO SPECT in depressed bipolar I patients |
| Q33796802 | Cognitive dysfunctions in bipolar disorder: evidence of neuropsychological disturbances. |
| Q51943686 | Cognitive function across manic or hypomanic, depressed, and euthymic states in bipolar disorder. |
| Q46719617 | Cognitive functioning in bipolar patients receiving lamotrigine: preliminary results |
| Q44874580 | Cognitive impairment in euthymic bipolar patients: implications for clinical and functional outcome. |
| Q39823908 | Cognitive variability in bipolar II disorder: who is cognitively impaired and who is preserved |
| Q57612858 | Comparison of Rapid-Cycling and Non–Rapid-Cycling Bipolar I Manic Patients During Treatment With Olanzapine |
| Q51896421 | Depression subtypes in bipolar I and II disorders. |
| Q48063999 | Diagnostic reliability in schizoaffective disorder |
| Q48105321 | Differential effectiveness of right unilateral versus bilateral electroconvulsive therapy in resistant bipolar depression |
| Q49054083 | Differential outcome of bipolar patients receiving antidepressant monotherapy versus combination with an antimanic drug. |
| Q51989727 | Do cognitive complaints in euthymic bipolar patients reflect objective cognitive impairment? |
| Q40521394 | Effects of functional remediation on neurocognitively impaired bipolar patients: enhancement of verbal memory. |
| Q44962387 | Effects on weight and outcome of long-term olanzapine-topiramate combination treatment in bipolar disorder. |
| Q50717892 | Efficacy of functional remediation in bipolar disorder: a multicenter randomized controlled study. |
| Q45822527 | Efficacy of psychoeducation on symptomatic and functional recovery in bipolar disorder |
| Q50586608 | Emotional hyperreactivity as a core dimension of manic and mixed states. |
| Q57612977 | Enhanced corticotropin response to corticotropin-releasing hormone as a predictor of mania in euthymic bipolar patients |
| Q37664710 | Enhancing medication adherence in patients with bipolar disorder |
| Q57612531 | Erratum to: A Critical Update on Psychological Interventions for Bipolar Disorders |
| Q40085552 | Ethical questions in human clinical psychopharmacology: should the focus be on placebo administration? |
| Q36327267 | Evidence-based research on the efficacy of psychologic interventions in bipolar disorders: a critical review |
| Q57612941 | Executive Function in Patients with Remitted Bipolar Disorder and Schizophrenia and Its Relationship with Functional Outcome |
| Q48966670 | Factors associated with initial treatment response with antidepressants in bipolar disorder |
| Q47959919 | Family functioning in bipolar disorder: Characteristics, congruity between patients and relatives, and clinical correlates. |
| Q39244259 | Faster onset of antimanic action with haloperidol compared to second-generation antipsychotics. A meta-analysis of randomized clinical trials in acute mania. |
| Q48278520 | Functional remediation for patients with bipolar II disorder: improvement of functioning and subsyndromal symptoms |
| Q64932291 | Functional remediation improves bipolar disorder functioning with no effects on brain-derived neurotrophic factor levels. |
| Q37034894 | Gaps and limitations of psychological interventions for bipolar disorders |
| Q46052484 | Gender differences in a cohort study of 604 bipolar patients: the role of predominant polarity |
| Q36746449 | Genetic variants associated with response to lithium treatment in bipolar disorder: a genome-wide association study |
| Q57700323 | Genome-wide association study of 40,000 individuals identifies two novel loci associated with bipolar disorder |
| Q39732399 | Genome-wide association study of 40,000 individuals identifies two novel loci associated with bipolar disorder |
| Q44048838 | Group psychoeducation for stabilised bipolar disorders: 5-year outcome of a randomised clinical trial. |
| Q57612560 | Has number of previous episodes any effect on response to group psychoeducation in bipolar patients? A 5-year follow-up post hoc analysis |
| Q35621218 | Hyperprolactinemia and medications for bipolar disorder: systematic review of a neglected issue in clinical practice. |
| Q36286408 | Identifying and improving non-adherence in bipolar disorders. |
| Q52559316 | Impact of a psychoeducational family intervention on caregivers of stabilized bipolar patients. |
| Q57612689 | Impact of caregiver group psychoeducation on the course and outcome of bipolar patients in remission: a randomized controlled trial |
| Q113205722 | Improving Depressive Symptoms through Personalised Exercise and Activation (IDEA): Study Protocol for a Randomised Controlled Trial |
| Q34447011 | Integrated treatment of first episode psychosis with online training (e-learning): study protocol for a randomised controlled trial |
| Q33444992 | Internet-based psychological interventions for bipolar disorder: Review of the present and insights into the future |
| Q56967644 | Investigating polygenic burden in age at disease onset in bipolar disorder: Findings from an international multicentric study |
| Q33455598 | Is a SIMPLe smartphone application capable of improving biological rhythms in bipolar disorder? |
| Q37835514 | Is psychoeducation for parents and teachers of children and adolescents with ADHD efficacious? A systematic literature review. |
| Q48606602 | Is schizoaffective disorder still a neglected condition in the scientific literature? |
| Q58465437 | Keeping therapies simple: psychoeducation in the prevention of relapse in affective disorders |
| Q57612644 | Long-Term Mental Health Resource Utilization and Cost of Care Following Group Psychoeducation or Unstructured Group Support for Bipolar Disorders |
| Q34307557 | Lower rate of depressive switch following antimanic treatment with second-generation antipsychotics versus haloperidol. |
| Q48883016 | Mania and depression. Mixed, not stirred. |
| Q37319766 | Mental imagery as an emotional amplifier: application to bipolar disorder |
| Q48537074 | Mood instability and functional recovery in bipolar disorders |
| Q43275792 | Neurocognitive dysfunctions in euthymic bipolar patients with and without prior history of alcohol use. |
| Q46796135 | Neuropsychological disturbances and cerebral blood flow in bipolar disorder |
| Q51030865 | Neuropsychological performance in depressed and euthymic bipolar patients. |
| Q37764207 | New treatment guidelines for acute bipolar depression: a systematic review |
| Q51958126 | Non-adherence in psychiatric disorders: misbehaviour or clinical feature? |
| Q60459757 | OpenSIMPLe: A real-world implementation feasibility study of a smartphone-based psychoeducation programme for bipolar disorder |
| Q57612980 | Personality Disorders in Bipolar II Patients |
| Q38128667 | Polarity index of psychological interventions in maintenance treatment of bipolar disorder |
| Q51577829 | Postpartum bipolar episodes are not distinct from spontaneous episodes: implications for DSM-V. |
| Q57612654 | Predominant polarity and temperament in bipolar and unipolar affective disorders |
| Q57612710 | Predominant polarity in bipolar disorder: Diagnostic implications |
| Q57612268 | Predominant polarity in bipolar disorders: refining or redefining diagnosis? |
| Q46073072 | Predominant previous polarity as an outcome predictor in a controlled treatment trial for depression in bipolar I disorder patients |
| Q90269656 | Prospective cohort study of early biosignatures of response to lithium in bipolar-I-disorders: overview of the H2020-funded R-LiNK initiative |
| Q57612793 | Psychoeducation Manual for Bipolar Disorder |
| Q58465458 | Psychoeducation as a Core Element of Psychological Approaches for Bipolar Disorders |
| Q51890716 | Psychoeducation for bipolar II disorder: an exploratory, 5-year outcome subanalysis. |
| Q33448472 | Psychoeducation in bipolar disorder with a SIMPLe smartphone application: Feasibility, acceptability and satisfaction. |
| Q43535196 | Psychoeducation in bipolar patients with comorbid personality disorders |
| Q36236433 | Psychoeducation: improving outcomes in bipolar disorder |
| Q36096475 | Psychosocial treatments for bipolar disorders |
| Q44385085 | Psychotic versus non-psychotic bipolar II disorder. |
| Q44247110 | Quetiapine in the treatment of rapid cycling bipolar disorder. |
| Q48735347 | Rates and clinical correlates of treatment non-adherence in schizoaffective bipolar patients. |
| Q38474943 | Risk factors for antidepressant-related switch to mania. |
| Q41434848 | Risk factors for rapid cycling in bipolar disorder. |
| Q43899269 | Role of risperidone in bipolar II: an open 6-month study. |
| Q60636856 | Self-Monitoring and Psychoeducation in Bipolar Patients with a Smart-phone application (SIMPLe) project: Preliminary results from a feasibility study |
| Q33443296 | Self-monitoring and psychoeducation in bipolar patients with a smart-phone application (SIMPLe) project: design, development and studies protocols |
| Q58465423 | Social cognition and its potential role in bipolar disorder roughening |
| Q57612842 | Stabilizing the stabilizer: group psychoeducation enhances the stability of serum lithium levels |
| Q30363434 | Sudden glory revisited: cognitive contents of hypomania. |
| Q57612993 | Suicidal Behavior in Bipolar I and Bipolar II Disorder |
| Q43947442 | Suicide risk in rapid cycling bipolar patients |
| Q37558582 | The International Society for Bipolar Disorders (ISBD) Task Force report on the nomenclature of course and outcome in bipolar disorders |
| Q30583384 | The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders |
| Q58465444 | The Pivotal Role of Psycho-Education in the Long-Term Treatment of Bipolar Disorder |
| Q57612800 | The Pivotal Role of Psychoeducation in the Long-Term Treatment of Bipolar Disorder |
| Q47970449 | The association between biological rhythms, depression, and functioning in bipolar disorder: a large multi-center study. |
| Q41817782 | The evolution of psychoeducation for bipolar disorder: from lithium clinics to integrative psychoeducation |
| Q57612580 | The impact of staging bipolar disorder on treatment outcome of family psychoeducation |
| Q58465514 | The mechanism of action of psychotherapy |
| Q36248350 | The nature and treatment of depression in bipolar disorder: a review and implications for future psychological investigation |
| Q38174531 | The need for a behavioural science focus in research on mental health and mental disorders. |
| Q51821207 | The need for publishing the silent evidence from negative trials. |
| Q57612450 | The prognostic role of perceived criticism, medication adherence and family knowledge in bipolar disorders |
| Q45031086 | The risk of Bipolar Disorders in Multiple Sclerosis. |
| Q37487446 | The road to DSM-V. Bipolar disorder episode and course specifiers. |
| Q38675731 | The role of family interventions in bipolar disorder: A systematic review |
| Q32148738 | The somatics of psyche: structural neuromorphometry of bipolar disorder. |
| Q45906308 | The symptom structure of bipolar acute episodes: in search for the mixing link. |
| Q37881968 | Therapeutic options in treatment-resistant depression |
| Q57612378 | Treatment adherence in bipolar I and schizoaffective disorder, bipolar type |
| Q51868094 | Treatment nonadherence and neurocognitive impairment in bipolar disorder. |
| Q57612984 | Treatment of Refractory Rapid Cycling Bipolar Disorder With Risperidone |
| Q45741513 | Treatment strategies according to clinical features in a naturalistic cohort study of bipolar patients: a principal component analysis of lifetime pharmacological and biophysic treatment options |
| Q37594155 | Treatment-resistant bipolar depression: towards a new definition. |
| Q51774286 | Unexplored areas of psychotherapy in bipolar disorder. |
| Q33826965 | Validation of the Italian Version of the Biological Rhythms Interview of Assessment in Neuropsychiatry (BRIAN): Some Considerations on its Screening Usefulness |
| Q36166534 | Validity and Reliability of the Italian Version of the Functioning Assessment Short Test (FAST) in Bipolar Disorder |
| Q35865593 | Validity and reliability of the Functioning Assessment Short Test (FAST) in bipolar disorder. |
| Q37171035 | Weight gain in bipolar disorder: pharmacological treatment as a contributing factor. |
| Q41716131 | What is the role of psychotherapy in the treatment of bipolar disorder? |
| Q51916677 | What really matters to bipolar patients' caregivers: sources of family burden. |
| Q37874779 | What we know and what we don't know about the treatment of schizoaffective disorder. |
| Q37834767 | When should mood stabilizers be withdrawn due to lack of efficacy? Some methodological considerations. |
| Q48203156 | e-HCL-32: a useful, valid and user friendly tool in the screening of bipolar II disorder |